Medical Countermeasures UK Commits £33.2 Million to Eight Vaccine Projects Targeting Ebola, Marburg, Plague and Other Epidemic ThreatsGlobal Biodefense StaffOctober 18, 2026
Research New Research Reveals How Seminal Fluid Actively Amplifies Mpox InfectivityGlobal Biodefense StaffSeptember 12, 2026
Defense + Military Pentagon Pain-Medication EUA Pathway Opens Amid Ongoing Iran ConflictGlobal Biodefense StaffSeptember 4, 2026
Saudi Arabia Clears Smallpox and Mpox Vaccine in Signal of Broadening Biodefense Preparedness Medical Countermeasures May 18, 2026 …
New CDC-Backed Study Quantifies COVID-19 Vaccine’s Transmission-Blocking Effect Medical Countermeasures May 16, 2026 …
ARPA-H Bets Big on Ambient Storage for Cell Therapies, Launching Program to Break the Cold Chain Medical Countermeasures May 15, 2026 …
New Insights Into Tularemia Pathogen May Inform Next-Generation Medical Countermeasures Medical Countermeasures May 14, 2026 …
BioNTech’s Manufacturing Retreat Signals a Broader Erosion of mRNA Vaccine Capacity Medical Countermeasures May 5, 2026 …
mRNA Vaccine Platform Shows Promise Against Pandemic Influenza Strains, Including H5N1 Medical Countermeasures April 26, 2026 …
UK Launches Phase 3 Trial of mRNA H5N1 Vaccine in Bid to Get Ahead of Next Pandemic Medical Countermeasures April 23, 2026 …
When Mpox Strikes the Eye: A Case for Combination Antiviral Therapy Medical Countermeasures April 16, 2026 …
Smallpox Preparedness Contracts Top $60 Million as U.S. and International Partners Bolster Biodefense Stockpiles Medical Countermeasures March 25, 2026 …
U.S. Government Expands Smallpox Stockpile With $54 Million VIGIV Contract, International Orders Add $6.6 Million Industry News March 25, 2026 …
UK Opens Moderna mRNA Vaccine Centre in Oxfordshire and Launches £50 Million Life-Sciences Fund Medical Countermeasures September 29, 2025 …
U.S. Expands Investments in Biodefense Preparedness Through New Medical Countermeasure Contracts Contracts + Grants September 23, 2025 …
New Study Reveals Key to Marburg and Ebola Virus Assembly, Opening Door to Broad-Spectrum Antivirals Pathogens September 23, 2025 …
Building Europe’s Health Shield: New EU4Health Calls Advance Medical Countermeasures and Diagnostics CBRNE September 22, 2025 …
New Antibiotic Options Show Promise Against Biothreat Pathogens Antimicrobial Resistance September 12, 2025 …
Nanoparticle Anthrax Vaccine Shows Promise in Enhancing Biodefense Preparedness Medical Countermeasures September 9, 2025 …
New Mutation and DNA Repeats Behind Ceftazidime Resistance in Melioidosis Bacterium Medical Countermeasures September 5, 2025 …
Appili Therapeutics Reports Strong Preclinical Protection from ATI-1701 Tularemia Vaccine Medical Countermeasures August 11, 2025 …
Pan-Coronavirus Drug Discovery Gets a Boost from Global AI Blind Challenge Medical Countermeasures July 28, 2025 …
